EcoDrugPlus

Ensembl ID : ENSOCUG00000026654
Gene Symbol: -
1 Cross references
445 Possible Orthologues:

Ensembl ID : ENSOCUG00000027097
Gene Symbol: -
1 Cross references
445 Possible Orthologues:

Ensembl ID : ENSOCUG00000027162
Gene Symbol: -
1 Cross references
445 Possible Orthologues:

Ensembl ID : ENSOCUG00000027590
Gene Symbol: -
1 Cross references
194 Possible Orthologues:

Ensembl ID : ENSOCUG00000031838
Gene Symbol: -
1 Cross references
201 Possible Orthologues:

Ensembl ID : ENSOCUG00000033240
Gene Symbol: -
1 Cross references
234 Possible Orthologues:

Ensembl ID : ENSOCUG00000037233
Gene Symbol: -
1 Cross references
234 Possible Orthologues:

Ensembl ID : ENSOCUG00000037631
Gene Symbol: -
1 Cross references
198 Possible Orthologues:

Ensembl ID : ENSOCUG00000038559
Gene Symbol: -
1 Cross references
267 Possible Orthologues:

Ensembl ID : ENSOCUG00000015239
Gene Symbol: -
1 Cross references
56 Possible Orthologues:

Ensembl ID : ENSOCUG00000001209
Gene Symbol: -
1 Cross references
114 Possible Orthologues:

Ensembl ID : ENSOCUG00000039274
Gene Symbol: -
1 Cross references
196 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).